Frederick G. Hayden, MD; Louis Diamond, PhD
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
Hayden F., Diamond L.; Cost and the Common Cold. Ann Intern Med. 1997;126:174. doi: 10.7326/0003-4819-126-2-199701150-00022
Download citation file:
Published: Ann Intern Med. 1997;126(2):174.
We agree with Mr. Vermeulen that prescribing decisions must be sensitive to cost issues. It is important to emphasize, however, that concern about economic factors should not deter clinical investigations designed to advance the understanding of pathogenic mechanisms and development of more effective therapy. Our study was conducted several years before (and submitted for publication several months before) intranasal ipratropium was approved by the Food and Drug Administration. Our results were not intended to endorse use of this product but rather to indicate its degree of clinical effectiveness and tolerability in adults with uncomplicated colds. Clearly, many health problems for which patients seek relief of symptoms are self-limiting (for example, analgesics for headache and minor pain and antitussives for cough). In addition, as recently documented by Mainous and colleagues , most patients treated in ambulatory settings for apparently uncomplicated colds receive a prescription for an antibiotic agent. Such inappropriate use of antibiotic agents raises several concerns, including the development of drug-resistant bacteria.
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only